Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
62.90B
Market cap62.90B
Price-Earnings ratio
17.66
Price-Earnings ratio17.66
Dividend yield
Dividend yield
Average volume
23.91M
Average volume23.91M
High today
$43.90
High today$43.90
Low today
$43.05
Low today$43.05
Open price
$43.08
Open price$43.08
Volume
29.28M
Volume29.28M
52 Week high
$105.65
52 Week high$105.65
52 Week low
$42.20
52 Week low$42.20

Stock Snapshot

The current Boston Scientific(BSX) stock price is $43.42, with a market capitalization of 62.9B. The stock trades at a price-to-earnings (P/E) ratio of 17.66.

On 2026-09-19, Boston Scientific(BSX) stock traded between a low of $43.05 and a high of $43.90. Shares are currently priced at $43.42, which is +0.9% above the low and -1.1% below the high.

The Boston Scientific(BSX)'s current trading volume is 29.28M, compared to an average daily volume of 23.91M.

During the past year, Boston Scientific(BSX) stock moved between $42.20 at its lowest and $105.65 at its peak.

During the past year, Boston Scientific(BSX) stock moved between $42.20 at its lowest and $105.65 at its peak.

BSX News

TipRanks 13h
Boston Scientific Advances Eso-SPONGE Trial, Targeting GI Leak Treatment and New Growth

Boston Scientific (BSX) announced an update on their ongoing clinical study. Boston Scientific Corp. is launching a new multicenter trial called “A Prospective...

TipRanks 23h
Analyst Maintains Buy on Boston Scientific, Viewing Cyberattack Impact as Short-Lived Despite Trimmed Near-Term Forecasts

Analyst Josh Jennings of TD Cowen maintained a Buy rating on Boston Scientific, with a price target of $56.00. Josh Jennings has given his Buy rating due to a c...

Seeking Alpha 2d
Boston Scientific downgraded at Citi on increasing competition, cyberattack fallout

Citi downgraded Boston Scientific (BSX) to Neutral from Buy, saying that it is still contending with the aftermath of an August cyberattack, as well as increase...

Boston Scientific downgraded at Citi on increasing competition, cyberattack fallout

Analyst ratings

82%

of 33 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

More BSX News

TipRanks 2d
Citi downgrades Boston Scientific to Neutral on uncertain recovery

Citi downgraded Boston Scientific (BSX) to Neutral from Buy with a price target of $50, down from $57. The company faces a “more mature” U.S. pulsed field ablat...

Simply Wall St 4d
Boston Scientific Faces Cyberattack And Recall Fallout, Is The Sell Off Overdone?

Advertisement Why Boston Scientific stock is in focus now Boston Scientific (BSX) is back on many watchlists after an August cyberattack disrupted manufacturi...

Boston Scientific Faces Cyberattack And Recall Fallout, Is The Sell Off Overdone?

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.